The FTSE 100 was up 0.2 per cent after the first hour of trading, having finished on a record high of 8,871.31 on Thursday.

This FTSE 100 pharmaceutical giant has been hit by fears of US tariffs and litigation over a key product, but this could mean ...

While cancelled NIH grants and regulatory uncertainty are less hospitable to clinical research in the U.S., Europe must play ...

The global patented drugs market revenue was around US$ 814.4 billion in 2022 and is estimated to reach US$ 1,456.5 billion by 2032 is growing at a compound annual growth rate (CAGR) of 6.0% during ...